Saba Labs Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Saba Labs General Information

Description

Developer of wound care products designed to treat chronic wounds. The company's products help doctors to treat patients who are suffering from complex, chronic or acute wounds such as surgical site infections, diabetic foot ulcers, venous leg ulcers, pressure ulcers and burns, enabling patients to recover from wounds and prevent infection on wound sites.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • 2501 20th Place South
  • Suite 275
  • Birmingham, AL 35223
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Saba Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 31-Jan-2020 00.000 Completed Out of Business
3. Seed Round 27-Jul-2017 00.000 00.000 Completed Startup
2. Angel (individual) 01-Jan-2016 $700K $700K Completed Startup
1. Angel (individual) 23-Aug-2016 Cancelled Startup
To view Saba Labs’s complete valuation and funding history, request access »